Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 4/20 | 0.80 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.71 |
| ▸ | GAA | P10253 | 1/20 | 0.70 |
| ▸ | MEN1 | O00255 | 2/20 | 0.68 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.68 |
| ▸ | TSHR | P16473 | 1/20 | 0.67 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.59 |
| ▸ | RAB9A | P51151 | 1/20 | 0.57 |
| ▸ | DPP4 | P27487 | 1/20 | 0.57 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.57 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.57 |
| ▸ | SGMS2 | Q8NHU3 | 1/20 | 0.56 |
| ▸ | CTSL | P07711 | 1/20 | 0.56 |
| ▸ | CTSB | P07858 | 1/20 | 0.56 |
| ▸ | CTSK | P43235 | 1/20 | 0.56 |
| ▸ | HPGD | P15428 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8393719 | 0.97 | EPHX1 (0.84) | EPHX1ALDH1A1GAAMEN1KMT2A | |
| SCHEMBL1424064 | 0.97 | EPHX1 (0.84) | EPHX1ALDH1A1GAAMEN1KMT2A | |
| Dimethylamine SCHEMBL8326428 | 0.96 | EPHX1 (0.78) | EPHX1ALDH1A1GAAMEN1KMT2A | |
| Bicarbonate SCHEMBL6203780 | 0.95 | EPHX1 (0.82) | EPHX1ALDH1A1GAAMEN1KMT2A | |
| SCHEMBL7198149 | 0.95 | EPHX1 (0.81) | EPHX1ALDH1A1GAAMEN1KMT2A | |
| SCHEMBL14612363 | 0.93 | EPHX1 (0.78) | EPHX1ALDH1A1GAAMEN1KMT2A | |
| Cyclobutylcarbamic Acid Benzyl Ester SCHEMBL332814 | 0.92 | EPHX1 (0.76) | EPHX1ALDH1A1GAAMEN1KMT2A | |
| Cyclobutylcarbamic Acid Benzyl Ester SCHEMBL579215 | 0.91 | EPHX1 (0.74) | EPHX1ALDH1A1GAAMEN1KMT2A | |
| SCHEMBL3948456 | 0.89 | ALDH1A1 (0.85) | EPHX1ALDH1A1GAAMEN1KMT2A | |
| SCHEMBL381922 | 0.89 | ALDH1A1 (0.85) | EPHX1ALDH1A1GAAMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6825191-B2 | ANTICOAGULANT | AJINOMOTO CO., INC. (JP) | 2004-11-30 | — | — | US | disclosed |
| US-20030186969-A1 | Benzodiazepine derivatives | AJINOMOTO CO. INC (JP) | 2003-10-02 | — | — | US | disclosed |
| EP-1329450-A1 | BENZODIAZEPINE DERIVATIVE | Ajinomoto Co., Inc. (JP) | 2003-07-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030186969-A1 | Benzodiazepine derivatives | GABRA1, F11, GABRA4 | EPHX1 1008/4885ALDH1A1 633/4885GAA 1539/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.